Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Iradimed (IRMD) Income from Continuing Operations (2016 - 2026)

Iradimed has reported Income from Continuing Operations over the past 14 years, most recently at 5818000.0 for Q1 2026.

  • Quarterly Income from Continuing Operations rose 24.13% to 5818000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 23610571.0 through Mar 2026, up 19.34% year-over-year, with the annual reading at 22480000.0 for FY2025, 16.88% up from the prior year.
  • Income from Continuing Operations was 5818000.0 for Q1 2026 at Iradimed, down from 6441958.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 6441958.0 in Q4 2025 and troughed at 2486713.0 in Q1 2022.
  • The 5-year median for Income from Continuing Operations is 4687000.0 (2025), against an average of 4478287.29.
  • Year-over-year, Income from Continuing Operations soared 120.53% in 2022 and then dropped 15.13% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 3673617.0 in 2022, then decreased by 15.13% to 3117741.0 in 2023, then soared by 65.08% to 5146752.0 in 2024, then increased by 25.17% to 6441958.0 in 2025, then fell by 9.69% to 5818000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Income from Continuing Operations are 5818000.0 (Q1 2026), 6441958.0 (Q4 2025), and 5576652.0 (Q3 2025).